By Sahil Pandey
March 10 (Reuters) – Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular in a deal valued at $550 million, expanding its line-up of products used in stroke care.
Shares of the company were down more than 1% in early trading.
Here are some details:
(Reporting by Sahil Pandey in Bengaluru; Editing by Jonathan Ananda)
